News

Medical Dialogues13m
Bayer Jivi gets USFDA approval for pediatric patients 7 years of age and older with hemophilia A
Whippany: Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Jivi, a recombinant DNA-derived, ...